Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05149313
What this trial is testing

Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine

Who this might be right for
Dermatitis, AtopicEczema
Almirall, S.A. 331
Not applicableNot Yet RecruitingNCT07276620
What this trial is testing

Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults

Who this might be right for
Atopic Dermatitis (AD)
Xiangya Hospital of Central South University 1,000
Large-scale testing (Phase 3)UnknownNCT04283968
What this trial is testing

Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Tel-Aviv Sourasky Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT03496974
What this trial is testing

A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Janssen Research & Development, LLC 38
Large-scale testing (Phase 3)Active Not RecruitingNCT06552520
What this trial is testing

To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07386743
What this trial is testing

A Phase III Study of GS101 Injection to Dupixent®

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu Genscend Biopharmaceutical Co., Ltd 572
Testing effectiveness (Phase 2)Study completedNCT06162507
What this trial is testing

Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 24
Early research (Phase 1)Study completedNCT02888704
What this trial is testing

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 13
Large-scale testing (Phase 3)Study completedNCT05194540
What this trial is testing

Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)

Who this might be right for
Atopic Dermatitis
LEO Pharma 136
Not applicableStudy completedNCT06421740
What this trial is testing

An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

Who this might be right for
Atopic Dermatitis
AbbVie 1,000
Large-scale testing (Phase 3)Study completedNCT02277743
What this trial is testing

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 671
Large-scale testing (Phase 3)Not Yet RecruitingNCT07540442
What this trial is testing

A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Shanghai Mabgeek Biotech.Co.Ltd 180
Not applicableStudy completedNCT05959083
What this trial is testing

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
AbbVie 200
Testing effectiveness (Phase 2)Ended earlyNCT03847389
What this trial is testing

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Hill Dermaceuticals, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT03585296
What this trial is testing

ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 22
Large-scale testing (Phase 3)UnknownNCT06216392
What this trial is testing

Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 450
Post-approval studies (Phase 4)Study completedNCT05680298
What this trial is testing

Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China

Who this might be right for
Atopic Dermatitis
Sanofi 34
Testing effectiveness (Phase 2)Study completedNCT06713499
What this trial is testing

A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Children and Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT06094179
What this trial is testing

Evaluate the Safety, Tolerability of BAT6026

Who this might be right for
Dermatitis, Atopic
Bio-Thera Solutions 33
Not applicableLooking for participantsNCT06815380
What this trial is testing

Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Almirall, S.A. 1,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation